Audentes Therapeutics Inc (BOLD_old)

NASDAQ
59.97
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    59.97 - 59.99
  • 52 wk Range:
    0.00 - 0.00

BOLD_old Overview

Prev. Close
59.98
Day's Range
59.97-59.99
Revenue
-
Open
59.98
52 wk Range
0-0
EPS
-3.98
Volume
0
Market Cap
2.77B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
382,291
P/E Ratio
-
Beta
2.18
1-Year Change
0%
Shares Outstanding
46,272,171
Next Earnings Date
-
What is your sentiment on Audentes Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Audentes Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Audentes Therapeutics Inc Analysis

Audentes Therapeutics Inc Company Profile

Audentes Therapeutics Inc Company Profile

Employees
207

Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. The company is developing AT132, which is in Phase I/II clinical studies for the treatment of X-linked myotubular myopathy (XLMTM); AT342 that is in Phase I/II clinical studies to treat crigler-najjar syndrome; AT845, which is in preclinical studies for the treatment of pompe disease; and AT307 to treat CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. It is also developing vectorized antisense treatments for the treatment of duchenne muscular dystrophy and myotonic dystrophy type 1. The company has a collaborative development agreement with Genethon to research, develop, manufacture, and commercialize products for the treatment of XLMTM; and a license and collaboration agreement with the University of Pennsylvania to research, develop, sell, and import licensed products for the treatment of crigler-najjar. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California. As of January 14, 2020, Audentes Therapeutics, Inc. operates as a subsidiary of Astellas US Holding, Inc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • This is proof that if you know what your doing you can make money
    0
    • Sure wish I knew about this company before today
      0
      • Exactly@Joe
        0
      • This is proof that if you know what your doing you can make money
        0